biotech
biotech Articles
The June 30 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
Published:
Last Updated:
Ocular Therapeutix shares were absolutely crushed on Wednesday after the company received less than favorable news from the FDA regarding its Dextenza in the treatment of ocular pain following...
Published:
Last Updated:
The biotech industry has made a splash in 2017, outperforming practically all the broad markets. With this incredible display, it's no wonder that investor interest in this particular industry has...
Published:
Last Updated:
In an incredible move on Friday, the FDA approved Endari for the treatment of patients age five and older with sickle cell disease to reduce severe complications that are common with the blood...
Published:
Last Updated:
This partnership should be fairly transformative for BeiGene, seeing as it can start making some actual money.
Published:
Last Updated:
Athenex led biotech stocks higher on Wednesday after its Chinese subsidiary submitted an Investigational New Drug application to the China Food and Drug Administration.
Published:
Last Updated:
Array BioPharma has announced the submission to the FDA of two New Drug Applications to support the use of the combination of binimetinib and encorafenib for the treatment of patients with melanoma.
Published:
Last Updated:
24/7 Wall St. has collected several catalysts that are coming up on the calendar in the month of July and added some color.
Published:
Last Updated:
Bluebird Bio shares have made a steady gain over the course of the year and now the firm is looking to cash in on this growth.
Published:
Last Updated:
Many on Wall Street feel that some of the more speculative institutional tech money may be rotating into the biotechs, and with good reason.
Published:
Last Updated:
The June 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
Published:
Last Updated:
Agio Pharmaceuticals saw its shares sink on Monday after the firm announced results from its midstage trial for the treatment of relapsed or refractory acute myeloid leukemia.
Published:
Last Updated:
Cara Therapeutics saw its shares rise on Friday after the company said that the FDA granted a Breakthrough Therapy designation on its uremic pruritus treatment.
Published:
Last Updated:
Jefferies has picked out a few companies in the biotech industry that stand to win big over the coming year.
Published:
Last Updated:
Clovis Oncology saw its shares make a handy gain in Wednesday’s session after the company priced its secondary offering.
Published:
Last Updated: